# Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders

> **NCT01831986** · NA · UNKNOWN · sponsor: **Sha'ar Menashe Mental Health Center** · enrollment: 60 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Pregnenolone and L-Theanine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01831986
- **Lead sponsor:** Sha'ar Menashe Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831986, "Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01831986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*